Acesso Biologics is a leading innovator in regenerative medicine, specializing in advanced amniotic tissue products designed to support natural healing and tissue repair. With a strong commitment to quality, safety, and clinical performance, Acesso Biologics provides biologic solutions that help healthcare professionals improve outcomes in wound care, surgical recovery, and specialized medical procedures.

Each of Acesso Biologics’ amniotic tissue products is developed through rigorous donor screening, advanced processing technologies, and strict quality control standards. Rich in growth factors, extracellular matrix proteins, and anti-inflammatory components, these products promote cellular regeneration, reduce inflammation, and create an optimal environment for tissue repair. They are widely used in the treatment of chronic wounds such as diabetic foot ulcers, pressure injuries, venous leg ulcers, as well as in surgical and orthopedic applications.

By combining scientific innovation with regulatory compliance and dependable manufacturing practices, Acesso Biologics ensures consistent product integrity and clinical reliability. The company partners with hospitals, wound care centers, and medical professionals to deliver effective regenerative solutions that enhance patient care and advance the future of biologic medicine.